William K. Evans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William K. Evans has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Andreas Laupacis
From the Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton; Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto; and Ministry of Health and Long-Term Care, Toronto, Ontario, Canada
1 shared publicationAnna Chyjek
Cancer Care Ontario, University of Toronto, Toronto, ON, Canada
1 shared publicationCarol Sawka
Cancer Care Ontario, University of Toronto, Toronto, ON, Canada
1 shared publicationKaren Y. Gulenchyn
From the Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton; Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto; and Ministry of Health and Long-Term Care, Toronto, Ontario, Canada
1 shared publicationLes Levin
From the Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton; Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto; and Ministry of Health and Long-Term Care, Toronto, Ontario, Canada
1 shared publicationMark Levine
From the Juravinski Cancer Centre at Hamilton Health Sciences and McMaster University, Hamilton; Keenan Research Centre at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and University of Toronto; and Ministry of Health and Long-Term Care, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- 1 July 2013
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 8 (7) , 876-882
Improving the Quality of Lung Cancer Care in Ontario: The Lung Cancer Disease Pathway Initiative
- 1 July 2013
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 8 (7) , 876-882
Improving the Quality of Lung Cancer Care in Ontario: The Lung Cancer Disease Pathway Initiative
- 1 May 2013
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 23 (2) , 225-232
Prognostic Implications of Treatment Delays in the Surgical Resection of Lung Cancer
- 1 May 2013
- Published by Elsevier in Thoracic Surgery Clinics
- Vol. 23 (2) , 225-232
Prognostic Implications of Treatment Delays in the Surgical Resection of Lung Cancer
- 1 November 2011
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (11) , 1781-1783
Computed Tomography Screening for Lung Cancer without a Smoking Cessation Program—Not a Cost-Effective Idea
- 1 November 2011
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (11) , 1781-1783
Computed Tomography Screening for Lung Cancer without a Smoking Cessation Program—Not a Cost-Effective Idea
- 20 November 2009
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (33) , 5607-5613
Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada
Purpose The uptake of new health care technologies is usually driven by industry promotion, physician interest, patient demand, and institutional ability to acquire the technology. The introduction of positron emission tomography (PET) scanning in the province of Ontario, Canada, followed a different path. Methods The Ontario provincial government, through its Ministry of Health and Long-Term Care, commissioned a systematic review of the literature. When this found only weak evidence that PET has a positive impact on clinical outcomes, the Ministry introduced a provincial PET evaluation program to close the evidence gap. Results This article describes the challenges encountered establishing the PET evaluation program. These included the design and conduct of the initial clinical trials, the establishment of a PET cancer registry, standardizing how PET scans were performed and reported, and gaining acceptance by health professionals for the evaluative program. Conclusion The proliferation of health technologies is a key driver of increasing health care costs. The Ontario approach to the introduction of PET is a model worth consideration by health systems seeking to ensure that they receive value for money based on a strong evidentiary base when introducing new health technologies.
- 20 November 2009
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (33) , 5607-5613
Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada
Purpose The uptake of new health care technologies is usually driven by industry promotion, physician interest, patient demand, and institutional ability to acquire the technology. The introduction of positron emission tomography (PET) scanning in the province of Ontario, Canada, followed a different path. Methods The Ontario provincial government, through its Ministry of Health and Long-Term Care, commissioned a systematic review of the literature. When this found only weak evidence that PET has a positive impact on clinical outcomes, the Ministry introduced a provincial PET evaluation program to close the evidence gap. Results This article describes the challenges encountered establishing the PET evaluation program. These included the design and conduct of the initial clinical trials, the establishment of a PET cancer registry, standardizing how PET scans were performed and reported, and gaining acceptance by health professionals for the evaluative program. Conclusion The proliferation of health technologies is a key driver of increasing health care costs. The Ontario approach to the introduction of PET is a model worth consideration by health systems seeking to ensure that they receive value for money based on a strong evidentiary base when introducing new health technologies.